ClinicalTrials.govpublic full text
Re-treatment of Participants With Paget's Disease Using Zoledronic Acid
paget's disease of the bone, paget's disease, zoledronic acid, reclast®/aclasta®, infusion, re-treatment, re-lapse, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 805960
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.